Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTEMTempus AI$52.32+9.4%$49.42$41.73▼$104.32$8.59B3.646.61 million shs10.21 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTEMTempus AI+9.41%+7.68%+19.10%+2.91%-26.54%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTEMTempus AI$52.32+9.4%$49.42$41.73▼$104.32$8.59B3.646.61 million shs10.21 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTEMTempus AI+9.41%+7.68%+19.10%+2.91%-26.54%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceTEMTempus AI 2.47Hold$68.6431.20% UpsideCurrent Analyst Ratings BreakdownLatest BRSC, RCP, CTY, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2026TEMTempus AI Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoveragePeer Perform6/1/2026TEMTempus AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$80.006/1/2026TEMTempus AI Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$75.005/11/2026TEMTempus AI HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $64.005/8/2026TEMTempus AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$90.00 ➝ $80.005/6/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $68.004/13/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$65.004/13/2026TEMTempus AI Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageUnderperform$35.003/30/2026TEMTempus AI GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $60.00(Data available from 6/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookTEMTempus AI$1.27B7.39N/AN/A$2.76 per share18.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateTEMTempus AI-$245.03M-$1.72N/AN/AN/A-22.20%-53.83%-11.17%8/14/2026 (Estimated)Latest BRSC, RCP, CTY, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026TEMTempus AI-$0.21-$0.13+$0.08-$0.71$345.44 million$348.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthTEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioTEMTempus AI2.963.313.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipTEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipTEMTempus AI24.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableTEMTempus AI3,800179.57 million136.00 millionN/ABRSC, RCP, CTY, and TEM HeadlinesRecent News About These CompaniesBest Artificial Intelligence Stocks To Keep An Eye On - June 15th16 minutes ago | americanbankingnews.comEntropy Technologies LP Purchases New Holdings in Tempus AI, Inc. $TEMJune 15 at 3:50 AM | marketbeat.comTempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity EmergingJune 13 at 5:25 AM | finance.yahoo.comTempus AI: AI Precision Medicine With A MoatJune 11, 2026 | seekingalpha.comTempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart RhythmJune 11, 2026 | businesswire.comFranklin Resources Inc. Has $109.94 Million Holdings in Tempus AI, Inc. $TEMJune 11, 2026 | marketbeat.comTempus AI (TEM) Is One Of The Best Healthcare Mid-Cap AI Stock According To AnalystsJune 10, 2026 | finance.yahoo.comAmova Asset Management Americas Inc. Has $206.96 Million Stock Position in Tempus AI, Inc. $TEMJune 10, 2026 | marketbeat.comTempus to Report First Quarter 2025 Financial Results on May 6June 9, 2026 | businesswire.comTempus AI could be creating an unstoppable data machineJune 9, 2026 | msn.comTempus AI: The Compression Has Outrun The Business - Upgrading To BuyJune 9, 2026 | seekingalpha.comGenetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome TestingJune 9, 2026 | businesswire.comTempus AI: A Unique AI Business Model With Asymmetric UpsideJune 9, 2026 | seekingalpha.comTempus AI, Inc. (NASDAQ:TEM) Given Average Rating of "Hold" by BrokeragesJune 9, 2026 | americanbankingnews.comAlethea Capital Management LLC Makes New Investment in Tempus AI, Inc. $TEMJune 9, 2026 | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Hold" from BrokeragesJune 9, 2026 | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Hold" by AnalystsJune 9, 2026 | americanbankingnews.comTempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by BrokeragesJune 9, 2026 | marketbeat.comTempus AI, Inc. (TEM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 8, 2026 | seekingalpha.comNorges Bank Purchases New Position in Tempus AI, Inc. $TEMJune 8, 2026 | marketbeat.comContrarius Group Holdings Ltd Makes New Investment in Tempus AI, Inc. $TEMJune 8, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBRSC, RCP, CTY, and TEM Company DescriptionsTempus AI NASDAQ:TEM$52.32 +4.50 (+9.41%) Closing price 06/15/2026 04:00 PM EasternExtended Trading$52.27 -0.05 (-0.10%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas What's Behind the Social Media Controversy Surrounding IonQ? Mission Control: Floating In SpaceX's Record-Breaking Orbit 3 Dividend Increases Investors Can Actually Trust RH’s Strong Q1 Still Leaves Investors With One Big Question SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? Alphabet's Most Overlooked Division Just Had a Big Week Robinhood Wants a Bigger Role in IPOs—Here's Why It Matters Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
